{
  "timestamp": "2026-01-08T14:22:48.331497",
  "dataset_file": "benchmark/datasets/01_matching_dataset.json",
  "evaluation_type": "comparison",
  "language": "vi",
  "total_topics": 10,
  "results": [
    {
      "topic_number": "1",
      "workflow": {
        "response": "Okay, I've reviewed the patient's information and the available clinical trials. Here are some potential matches:\n\n1.  **NCT01816295** `COMPLETED`\n\n### Testosterone Solution for Hypogonadal Men\n\n**Match Score:** 0.00% | **Phase:** PHASE3 | **[NCT01816295](https://clinicaltrials.gov/study/NCT01816295)**\n\n**Why it fits:** This trial is for men with low testosterone (hypogonadism). The patient's low testosterone and low GnRH levels suggest hypogonadism.\n\n**Conditions:** Hypogonadism\n\n**Locations:** For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., A Coru√±a, Spain; For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Ancona, Italy; For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Aravaca, Spain; For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Austin, Texas, United States\n\n---\n\n2.  **NCT05541172** `RECRUITING`\n\n### Testosterone Undecanoate Replacement Therapy in Boys With Pubertal Delay or Confirmed Hypogonadism\n\n**Match Score:** 0.00% | **Phase:** NA | **[NCT05541172](https://clinicaltrials.gov/study/NCT05541172)**\n\n**Why it fits:** This trial is for boys with delayed puberty or confirmed hypogonadism. The patient's delayed puberty and low testosterone levels suggest this possibility.\n\n**Conditions:** Delayed Puberty, Male Hypogonadism\n\n**Locations:** Rodolfo Rey, Buenos Aires, Distrito Federal, Argentina\n\n---\n\n3.  **NCT00472940** `COMPLETED`\n\n### Prevalence of Hypogonadism in Male Cancer Patients\n\n**Match Score:** 0.00% | **Phase:** NA | **[NCT00472940](https://clinicaltrials.gov/study/NCT00472940)**\n\n**Why it fits:** This trial is for male cancer patients. While the patient's primary concern is sexual, the presence of hypogonadism could be related to their cancer treatment or the cancer itself.\n\n**Conditions:** Cancer, Hypogonadism\n\n**Locations:** Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, United States\n\n---\n\n4.  **NCT04922385** `UNKNOWN`\n\n### Cognitive Behavioural Therapy for Sexual Concerns During Perimenopause\n\n**Match Score:** 0.00% | **Phase:** NA | **[NCT04922385](https://clinicaltrials.gov/study/NCT04922385)**\n\n**Why it fits:** This trial is for women experiencing sexual concerns during perimenopause. The patient is a male, so this trial is not relevant.\n\n**Conditions:** Perimenopause, Sexual Concerns\n\n**Locations:** St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada\n\n---\n\n5.  **NCT01003392** `UNKNOWN`\n\n### Study of Coffee and Its Influence on the Heart in Normal People, Those With Coronary Artery Disease and Diabetics.\n\n**Match Score:** 0.00% | **Phase:** NA | **[NCT01003392](https://clinicaltrials.gov/study/NCT01003392)**\n\n**Why it fits:** This trial is for people with coronary artery disease. The patient's primary concern is sexual, and there is no indication of coronary artery disease.\n\n**Conditions:** Coronary Artery Disease\n\n**Locations:** Heart Institute (InCor), Univ. of Sao Paulo Medical School, S√£o Paulo, S√£o Paulo, Brazil\n\n---\n\nI've provided a few potential matches. Given the patient's age and symptoms, the testosterone deficiency is the most prominent factor. Would you like me to elaborate on any of these trials, or perhaps compare them?",
        "trial_ids": [
          "NCT01816295",
          "NCT05541172",
          "NCT00472940",
          "NCT04922385",
          "NCT01003392"
        ],
        "trial_count": 5,
        "execution_time": 17.91,
        "tokens": {
          "prompt_tokens": 1586,
          "completion_tokens": 1177,
          "total_tokens": 2763
        },
        "llm_scores": {
          "trial_id_count": 5,
          "trial_ids_extracted": [
            "NCT01816295",
            "NCT05541172",
            "NCT00472940",
            "NCT04922385",
            "NCT01003392"
          ],
          "depth": 3,
          "depth_reasoning": "Provides brief trial-by-trial comments referencing hypogonadism, delayed puberty, and sexual concerns, but reasoning is superficial, does not use the full endocrine profile (low GnRH, anosmia suggesting Kallmann) or age/location fit, and includes obviously mismatched trials despite acknowledging irrelevance.",
          "relevance": 3,
          "relevance_reasoning": "User asked to find trials for this specific 19-year-old male with hypogonadotropic hypogonadism features; response lists some hypogonadism/delayed puberty trials but also includes clearly irrelevant cancer, perimenopausal female, and coronary artery disease/coffee trials, and does not filter by geography or better phenotype match.",
          "clarity": 4,
          "clarity_reasoning": "Well-structured with numbered list, headings, and a short explanation for each trial; easy to read, though inclusion of irrelevant trials without a clear separation of non-candidates slightly reduces clarity of purpose.",
          "completeness": 3,
          "completeness_reasoning": "Addresses the main issue of hypogonadism/delayed puberty in a couple of trials but fails to consider key aspects like suspected Kallmann syndrome (anosmia + low GnRH), appropriate age/sex inclusion criteria in detail, and excludes a focused set of actually suitable trials; inclusion of unrelated trials also suggests incomplete screening for appropriateness."
        }
      },
      "language": "vi"
    },
    {
      "topic_number": "2",
      "workflow": {
        "response": "Okay, I've reviewed the patient information and the available clinical trials. Here are some potential matches:\n\n1.  **NCT01768247** `UNKNOWN`\n\n### HCG Priming for Thin Endometrium in IVF\n\n**Match Score:** 0.00% | **Phase:** Phase4 | **[NCT Link](https://clinicaltrials.gov/study/NCT01768247)**\n\n**Why it fits:** This trial investigates the use of HCG priming to improve endometrial thickness in IVF. The patient's thin endometrium and history of infertility could make her a potential candidate.\n\n**Conditions:**\n- Endometrial Thickness\n- Pregnancy Outcome\n\n**Locations:**\nüìç Thessaloniki, Kalamaria, Greece\n\n---\n\n2.  **NCT02973230** `COMPLETED`\n\n### Serum Vascular Endothelial Growth Factor (VEGF) As a Marker for Tubal Pregnancy\n\n**Match Score:** 0.00% | **Phase:** Phase4 | **[NCT Link](https://clinicaltrials.gov/study/NCT02973230)**\n\n**Why it fits:** This trial explores the use of VEGF as a marker for tubal pregnancy. The patient's positive pregnancy test and ultrasound findings (no gestational sac in the uterus) could be relevant.\n\n**Conditions:**\n- Pregnancy\n- Ectopic\n\n**Locations:**\nüìç S√£o Paulo, S√£o Paulo, Brazil\n\n---\n\n3.  **NCT03770026** `COMPLETED`\n\n### Intrauterine Infusion of Autologous Platelet-rich Plasma to Prevent a Thin Endometrium in Infertile Women Undergoing Clomiphene Citrate Therapy: a Pilot Prospective Self-controlled Trial\n\n**Match Score:** 0.00% | **Phase:** Phase2/PHASE3 | **[NCT Link](https://clinicaltrials.gov/study/NCT03770026)**\n\n**Why it fits:** This trial investigates the use of platelet-rich plasma to improve endometrial thickness in women undergoing clomiphene citrate therapy. The patient's thin endometrium and history of infertility could make her a potential candidate.\n\n**Conditions:**\n- Infertility\n- Female\n- Associated With Anovulation\n\n**Locations:**\nüìç Banha Faculty Hospital, BanhƒÅ, Alkalubia, Egypt\n\n---\n\nI've found a few trials that might be relevant to your patient. The HCG priming trial (NCT01768247) and the VEGF trial (NCT02973230) are the most promising, given the patient's thin endometrium and positive pregnancy test. The platelet-rich plasma trial (NCT03770026) is also a possibility, but the patient's history of infertility is less directly relevant.\n\nWould you like me to summarize any of these trials in more detail, or perhaps compare them to see which one might be the best fit?",
        "trial_ids": [
          "NCT01768247",
          "NCT02973230",
          "NCT03770026"
        ],
        "trial_count": 3,
        "execution_time": 13.02,
        "tokens": {
          "prompt_tokens": 1311,
          "completion_tokens": 651,
          "total_tokens": 1962
        },
        "llm_scores": {
          "trial_id_count": 3,
          "trial_ids_extracted": [
            "NCT01768247",
            "NCT02973230",
            "NCT03770026"
          ],
          "depth": 2,
          "depth_reasoning": "Provides brief trial-specific comments but with incorrect or superficial clinical reasoning. Mischaracterizes the patient as having thin endometrium/infertility and does not integrate key features (early pregnancy, abnormal Œ≤-hCG rise, pregnancy of unknown location/possible ectopic). Matching logic is very shallow and in parts clearly inappropriate.",
          "relevance": 2,
          "relevance_reasoning": "User asks to find trials for a 32-year-old with suspected ectopic/pregnancy of unknown location. Only one trial (VEGF marker for tubal pregnancy) is plausibly related; the others are infertility/thin endometrium in IVF, which do not fit the scenario. It also suggests completed trials as options. Overall only loosely answers the request to find truly relevant current trials for this patient.",
          "clarity": 4,
          "clarity_reasoning": "The response is well-structured, readable, and uses consistent formatting. Each trial is clearly labeled with ID, title, conditions, and location. Despite clinical mismatches, the text itself is easy to follow with only minor issues (e.g., vague ‚Äòmatch score 0%‚Äô).",
          "completeness": 2,
          "completeness_reasoning": "Considers only a very narrow slice of the clinical picture (endometrial thickness, vague pregnancy) and ignores critical aspects such as suspected ectopic pregnancy management, hemodynamic status, gestational age, and safety/urgency. Does not discuss inclusion/exclusion in any depth, trial status (two are completed), or whether recruitment is ongoing. Many key aspects of the patient profile and user‚Äôs need for appropriate trial options are missing or mishandled."
        }
      },
      "language": "vi"
    },
    {
      "topic_number": "3",
      "workflow": {
        "response": "Okay, I've reviewed the patient information and the available trial data. Here are some potential trial matches:\n\n1.  **NCT00413764** `COMPLETED`\n\n### A Multicenter, Randomized, Double-Blind, Double Dummy Trial to Compare the Effects Tibolone and Transdermal Continuous Combined Estradiol/Norethisterone on Sexual Desire and Arousal in Postmenopausal Women With Sexual Dysfunction\n\n**Match Score:** 0.00% | **Phase:** Phase3 | **[NCT Link](https://clinicaltrials.gov/study/NCT00413764)**\n\n**Why it fits:** This trial is for postmenopausal women with sexual dysfunction, which aligns with the patient's decreased libido.\n\n**Conditions:**\n- Sexual Dysfunction\n\n**Locations:**\nüìç Milan, Italy\nüìç U.O. Medicina Interna 1/B, Milan, Italy\n\n---\n\n2.  **NCT06148623** `COMPLETED`\n\n### Clinical Performance Testing of Philips FAST SpO2 With Masimo Pulse Oximetry Sensors Across Skin Pigmentation\n\n**Match Score:** 0.00% | **Phase:** NA | **[NCT Link](https://clinicaltrials.gov/study/NCT06148623)**\n\n**Why it fits:** This trial is for testing a pulse oximeter, which is not directly related to the patient's condition.\n\n**Conditions:**\n- Healthy\n\n**Locations:**\nüìç Irvine, California, United States\nüìç Masimo Corporation, Irvine, California, United States\n\n---\n\n3.  **NCT00658164** `UNKNOWN`\n\n### None\n\n**Match Score:** 0.00% | **Phase:** Phase3 | **[NCT Link](https://clinicaltrials.gov/study/NCT00658164)**\n\n**Why it fits:** This trial is for Nonalcoholic Fatty Liver Disease, which is not related to the patient's condition.\n\n**Conditions:**\n- Nonalcoholic Fatty Liver Disease\n\n**Locations:**\nüìç Milan, Italy\nüìç U.O. Medicina Interna 1/B, Milan, Italy\n\n---\n\nI'm sorry, but I couldn't find any trials that directly match the patient's condition. The patient has hemochromatosis, which is a genetic disorder causing iron overload. There are no trials currently recruiting for this specific condition.",
        "trial_ids": [
          "NCT00413764",
          "NCT06148623",
          "NCT00658164"
        ],
        "trial_count": 3,
        "execution_time": 9.38,
        "tokens": {
          "prompt_tokens": 1403,
          "completion_tokens": 537,
          "total_tokens": 1940
        },
        "llm_scores": {
          "trial_id_count": 3,
          "trial_ids_extracted": [
            "NCT00413764",
            "NCT06148623",
            "NCT00658164"
          ],
          "depth": 2,
          "depth_reasoning": "Gives brief, mostly incorrect or superficial \"why it fits\" statements; does not use key clinical features (hemochromatosis, iron overload, age, sex, genetics) to reason about inclusion/exclusion. Two trials are explicitly unrelated and one is clearly mismatched (postmenopausal women vs 51‚Äëyear‚Äëold man). No nuanced clinical matching or discussion of why no appropriate hemochromatosis trials were found.",
          "relevance": 2,
          "relevance_reasoning": "User asked for trials for a man with hereditary hemochromatosis. All three listed trials are non‚Äëhemochromatosis and effectively 0% matches; one is for postmenopausal women, others for healthy subjects and NAFLD. The answer ends by stating there are no hemochromatosis trials, which is partially responsive, but most of the content is irrelevant trial listings.",
          "clarity": 4,
          "clarity_reasoning": "Formatting is clean, each trial is clearly separated with IDs, titles, conditions, and locations. The narrative is easy to read. The main clarity issue is conceptual (misleading justification of match), not linguistic or structural.",
          "completeness": 2,
          "completeness_reasoning": "Does not meaningfully use the detailed patient profile (genotype, ferritin, transferrin saturation, lack of comorbidities) to search or discuss relevant trials. Provides no actual hemochromatosis or iron‚Äëoverload studies, no discussion of management context or trial types that might exist, and ends with an unsupported claim that there are no recruiting trials. Only minimally addresses the request to find appropriate trials for this specific patient."
        }
      },
      "language": "vi"
    },
    {
      "topic_number": "4",
      "workflow": {
        "response": "Okay, I'm ready to help find some clinical trials for this patient.\n\nHere are a few trials that might be relevant, based on the information you provided:\n\n---\n\n**NCT06998628** `RECRUITING`\n\n### Clinical Study Evaluating the Effect of Pentoxifylline as Anti Inflammatory in Patients With Rheumatoid Arthritis\n\n**Match Score:** 0.00% | **Phase:** PHASE2 | [NCT06998628](https://clinicaltrials.gov/study/NCT06998628)\n\n**Why it fits:** This trial is looking for patients with Rheumatoid Arthritis. While the patient's symptoms are more suggestive of osteoarthritis, the trial may still be worth considering.\n\n**Conditions:**\n- Rheumatoid Arthritis\n\n**Locations:**\nüìç Faculty of Medicine, Al-Azhar University, Damietta, Damietta Governorate, Egypt\n\n---\n\n**NCT04612283** `COMPLETED`\n\n### A Double Blind, Randomized, Parallel Group Study to Evaluate Efficacy and Safety of NGA-01 Gel Against Placebo in the Treatment of Osteoarthritis With Joint Pain\n\n**Match Score:** 0.00% | **Phase:** PHASE2/PHASE3 | [NCT04612283](https://clinicaltrials.gov/study/NCT04612283)\n\n**Why it fits:** This trial is looking for patients with Osteoarthritis with joint pain. The patient's symptoms are consistent with this condition.\n\n**Conditions:**\n- Arthritis Osteoarthritis\n\n**Locations:**\nüìç Moraya Multispeciality Hospital, Pune, Maharashtra, India\n\n---\n\n**NCT02318875** `COMPLETED`\n\n### Investigation of Kritech Efficacy on Subjects Having Functional Discomfort Associated to Joints and Muscles Disorders\n\n**Match Score:** 0.00% | **Phase:** PHASE3 | [NCT02318875](https://clinicaltrials.gov/study/NCT02318875)\n\n**Why it fits:** This trial is looking for subjects having functional discomfort associated to joints and muscles disorders. The patient's symptoms are consistent with this condition.\n\n**Conditions:**\n- Pain\n\n**Locations:**\nüìç Plateforme de Recherche Clinique - CIC1401- Plurith√©matique Tripode 13A3 H√¥pital PELLEGRIN, Bordeaux, France\n\n---\n\n**NCT00056602** `COMPLETED`\n\n### Clinically Important Changes in Rheumatoid Arthritis\n\n**Match Score:** 0.00% | **Phase:** N/A | [NCT00056602](https://clinicaltrials.gov/study/NCT00056602)\n\n**Why it fits:** This trial is looking for patients with Rheumatoid Arthritis. While the patient's symptoms are more suggestive of osteoarthritis, the trial may still be worth considering.\n\n**Conditions:**\n- Rheumatoid Arthritis\n\n**Locations:**\nüìç National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States\n\n---\n\nI've provided a few options. Would you like me to summarize any of these trials in more detail, or perhaps compare them to see if one is a better fit?",
        "trial_ids": [
          "NCT06998628",
          "NCT04612283",
          "NCT02318875",
          "NCT00056602"
        ],
        "trial_count": 4,
        "execution_time": 12.14,
        "tokens": {
          "prompt_tokens": 1330,
          "completion_tokens": 728,
          "total_tokens": 2058
        },
        "llm_scores": {
          "trial_id_count": 4,
          "trial_ids_extracted": [
            "NCT06998628",
            "NCT04612283",
            "NCT02318875",
            "NCT00056602"
          ],
          "depth": 3,
          "depth_reasoning": "Provides a brief ‚ÄòWhy it fits‚Äô for each trial and acknowledges OA vs RA, but does not use the full clinical picture (age, comorbid HTN/hyperlipidemia, functional status, radiographic OA findings, location constraints, recruiting status) to reason through eligibility or quality of match; no discussion of key inclusion/exclusion criteria.",
          "relevance": 3,
          "relevance_reasoning": "User asked to find trials for this specific OA-like patient. Response does list several trials with some matching rationale, but half of them are RA-focused and completed, and it does not tailor selections strongly to this OA case or likely geography; partially addresses request but with notable mismatch and low match scores.",
          "clarity": 5,
          "clarity_reasoning": "Well-structured with clear headings, NCT IDs, status, phase, conditions, locations, and short explanations; easy to read and understand.",
          "completeness": 3,
          "completeness_reasoning": "Identifies OA and joint pain trials and mentions RA as differential, but ignores many key aspects: age, sex, comorbidities, radiographic OA features, need for active/recruiting trials, likely country/region, and more precise OA phenotype (hand and knee). Does not filter out clearly irrelevant or completed trials, so coverage of the patient‚Äôs real needs is only partial."
        }
      },
      "language": "vi"
    },
    {
      "topic_number": "5",
      "workflow": {
        "response": "Okay, I've reviewed the patient information and the available trial data. Here are some potential trial matches:\n\n1.  **NCT00489957** `COMPLETED`\n\n### Speckle Tracking and Function Assessment in Pediatric Patients\n\n**Match Score:** 0.00% | **Phase:** NA | **[NCT Link](https://clinicaltrials.gov/study/NCT00489957)**\n\n**Why it fits:** This trial is about cardiomyopathy in children, but the patient is 23 years old, so it's unlikely to be a good match.\n\n**Conditions:**\n- Cardiomyopathy\n\n**Locations:**\nüìç Emory University, Atlanta, Georgia, United States\n\n---\n\n2.  **NCT01498471** `WITHDRAWN`\n\n### NICE Guideline 'Red Flags' to Predict Serious Outcome After Transient Loss of Consciousness: Prospective Validation Study in the Emergency Department.\n\n**Match Score:** 0.00% | **Phase:** NA | **[NCT Link](https://clinicaltrials.gov/study/NCT01498471)**\n\n**Why it fits:** This trial is about syncope, but the patient's symptoms are related to exercise and the ultrasound shows asymmetrical septal hypertrophy, which is not directly related to syncope.\n\n**Conditions:**\n- Syncope\n\n**Locations:**\nüìç University Hospitals Leuven, Leuven, Belgium\n\n---\n\n3.  **NCT03302286** `COMPLETED`\n\n### Effects of Extra Corporeal Circuit Prime on Electrolytes Balance and Clinical Outcome Following Cardiac Surgery\n\n**Match Score:** 0.00% | **Phase:** NA | **[NCT Link](https://clinicaltrials.gov/study/NCT03302286)**\n\n**Why it fits:** This trial is about cardiac surgery, but the patient has no history of cardiac surgery.\n\n**Conditions:**\n- Cardiac Surgery\n\n**Locations:**\nüìç Thorax, Lund, Sk√•ne County, Sweden\n\n---\n\n4.  **NCT06939153** `RECRUITING`\n\n### Effects of Age, Sex and Isometric Exercise on Ventricular-Vascular Interactions During Cardiac Unloading\n\n**Match Score:** 0.00% | **Phase:** NA | **[NCT Link](https://clinicaltrials.gov/study/NCT06939153)**\n\n**Why it fits:** This trial is about orthostatic intolerance, but the patient's symptoms are related to exercise and the ultrasound shows asymmetrical septal hypertrophy, which is not directly related to orthostatic intolerance.\n\n**Conditions:**\n- Orthostatic Intolerance\n\n**Locations:**\nüìç University of Massachusetts Boston, Boston, Massachusetts, United States\n\n---\n\n5.  **NCT00862407** `ACTIVE_NOT_RECRUITING`\n\n### Impact of Pulsatile CPB on Vital Organ Recovery\n\n**Match Score:** 0.00% | **Phase:** NA | **[NCT Link](https://clinicaltrials.gov/study/NCT00862407)**\n\n**Why it fits:** This trial is about cardio-pulmonary bypass, but the patient has no history of cardiac surgery.\n\n**Conditions:**\n- Cardio-Pulmonary Bypass\n\n**Locations:**\nüìç Penn State College of Medicine, Hershey, Pennsylvania, United States\n\n---\n\nI've reviewed the available trials and the patient's information. Unfortunately, there are no trials that appear to be a strong match based on the provided data. The patient's symptoms and the ultrasound findings don't directly align with the conditions or goals of the listed trials.",
        "trial_ids": [
          "NCT00489957",
          "NCT01498471",
          "NCT03302286",
          "NCT06939153",
          "NCT00862407"
        ],
        "trial_count": 5,
        "execution_time": 12.63,
        "tokens": {
          "prompt_tokens": 1204,
          "completion_tokens": 800,
          "total_tokens": 2004
        },
        "llm_scores": {
          "trial_id_count": 5,
          "trial_ids_extracted": [
            "NCT00489957",
            "NCT01498471",
            "NCT03302286",
            "NCT06939153",
            "NCT00862407"
          ],
          "depth": 3,
          "depth_reasoning": "The assistant briefly comments for each trial why it likely does NOT fit (age mismatch, surgical history, etiology of syncope/orthostatic intolerance), which shows some use of patient characteristics and basic reasoning. However, it does not delve into the clear underlying diagnosis (hypertrophic cardiomyopathy with exertional syncope and family history of sudden death), does not actively search or reason about trials that would be appropriate for that condition, and applies superficial logic with some incorrect statements (e.g., saying asymmetric septal hypertrophy is not related to syncope). Overall, there is minimal true matching depth and limited clinical insight.",
          "relevance": 2,
          "relevance_reasoning": "The user asked to find clinical trials for this specific patient with classic hypertrophic obstructive cardiomyopathy features. The response lists several trials that are clearly irrelevant (pediatric imaging, CPB, cardiac surgery, orthostatic intolerance) and then concludes there is no strong match, instead of focusing on or attempting to identify HCM-related or sudden death risk‚Äìrelated trials. Much of the content is about why the shown trials do NOT match rather than answering the core request to find relevant trials, so overall relevance to the user‚Äôs goal is low.",
          "clarity": 4,
          "clarity_reasoning": "The response is well structured (numbered list, titles, status, brief explanation per trial) and easy to follow. The organization is clear and professional even though some clinical reasoning is flawed. Minor ambiguities aside, the presentation itself is straightforward and understandable.",
          "completeness": 2,
          "completeness_reasoning": "The patient profile strongly suggests hypertrophic cardiomyopathy with exertional syncope and a malignant family history. The response does not leverage these key aspects (age, suspected HCM, risk of sudden death, exertional syncope) to seek or propose relevant interventional or observational HCM/sudden death prevention trials. Instead, it presents a few obviously mismatched trials and then stops, without exploring appropriate condition-specific studies or discussing why none can be found for HCM if that is truly the case. Thus, core aspects of the profile and the matching task are largely unaddressed."
        }
      },
      "language": "vi"
    },
    {
      "topic_number": "6",
      "workflow": {
        "response": "Okay, I'm ready to help find a clinical trial for this patient.\n\nHere are some trial matches that might be relevant, based on the information you provided:\n\n---\n\n**NCT06541470** `COMPLETED`\n\n### IMAGE-GUIDED PLEURAL NEEDLE BIOPSY IN THE DIAGNOSIS OF PLEURAL DISEASES: ABRAMS NEEDLE OR CUTTING NEEDLE\n\n**Match Score:** 0.00% | **Phase:** NA | [NCT06541470](https://clinicaltrials.gov/study/NCT06541470)\n\n**Why it fits:** This trial involved pleural needle biopsy, which was performed on the patient.\n\n**Conditions:**\n- Biopsy\n- Diagnosis\n- Pleura\n- Exudate\n\n**Locations:**\nüìç Eski≈üehir, Turkey (T√ºrkiye)\nüìç Eskisehir Osmangazi University Medical Faculty Department of Chest Diseases, Turkey (T√ºrkiye)\nüìç ESOGU Medical Faculty Department of Chest Diseases, Turkey (T√ºrkiye)\nüìç Muzaffer Metintas, Turkey (T√ºrkiye)\n\n---\n\nI'm sorry, but I couldn't find any other trials that match the patient's profile.",
        "trial_ids": [
          "NCT06541470"
        ],
        "trial_count": 1,
        "execution_time": 6.79,
        "tokens": {
          "prompt_tokens": 1317,
          "completion_tokens": 263,
          "total_tokens": 1580
        },
        "llm_scores": {
          "trial_id_count": 1,
          "trial_ids_extracted": [
            "NCT06541470"
          ],
          "depth": 2,
          "depth_reasoning": "Provides only a very brief, superficial explanation: the trial is about pleural needle biopsy and the patient had a pleural biopsy. No discussion of the actual likely diagnosis (malignant pleural mesothelioma), disease stage, treatment options, or how the trial‚Äôs purpose aligns with the patient‚Äôs current clinical need (therapy vs. diagnostic procedure already done).",
          "relevance": 2,
          "relevance_reasoning": "User asks to find clinical trials for a 61-year-old man with findings consistent with malignant pleural mesothelioma. The assistant returns a single completed, diagnostic biopsy trial with 0% match score and no therapeutic relevance, then states no other trials are found. This is only tangentially related and does not meaningfully answer the request for trials appropriate for this patient‚Äôs condition.",
          "clarity": 4,
          "clarity_reasoning": "The response is short, structured, and easy to read with clear labeling of the trial and a brief explanation. Minor issue: stating a 0.00% match while presenting it as a relevant match may cause some confusion, but overall the text is understandable.",
          "completeness": 1,
          "completeness_reasoning": "Severely incomplete. Only one completed diagnostic trial is listed, with no attempt to find active treatment or management trials for pleural malignancy/mesothelioma, no consideration of age, comorbidities, smoking history, or geography, and no discussion of inclusion/exclusion or trial types. It addresses almost none of the key aspects of the patient profile or the user‚Äôs request for appropriate clinical trial options."
        }
      },
      "language": "vi"
    },
    {
      "topic_number": "7",
      "workflow": {
        "response": "Okay, I understand. I will act as a clinical trial matching assistant, presenting trial matches clearly and conversationally, following the specified format and tone guidelines. I will only use the provided matched trials and will respond in the same language as the user's input.\n\nHere are the trial matches for the patient you described:\n\n1.  **NCT06657495** `RECRUITING`\n\n    ### Th·ª≠ Nghi·ªám L√¢m S√†ng Giai ƒêo·∫°n 2, Ng·∫´u Nhi√™n, M√π ƒê√¥i, C√≥ ƒê·ªëi Ch·ª©ng Gi·∫£ D∆∞·ª£c ƒê·ªÉ ƒê√°nh Gi√° T√≠nh an To√†n V√† Hi·ªáu Qu·∫£ C·ªßa Vi√™n Ho√†n C·ª©ng TD0015 Tr√™n B·ªánh Nh√¢n Tho√°i H√≥a Kh·ªõp G·ªëi\n\n    **Match Score:** 0.00% | **Phase:** PHASE2 | **[NCT Link](https://clinicaltrials.gov/study/NCT06657495)**\n\n    **Why it fits:** No eligibility criteria available\n\n    **Conditions:** Knee Osteoarthritis\n\n    **Locations:** National Hospital of Traditional Medicine, Hanoi, Vietnam\n\n2.  **NCT03845348** `UNKNOWN`\n\n    ### ƒê√°nh gi√° hi·ªáu qu·∫£ ƒëi·ªÅu tr·ªã vi√™m da d·∫ßu ·ªü ƒë·∫ßu c·ªßa d·∫ßu g·ªôi Th√°i D∆∞∆°ng 3 v√† Th√°i D∆∞∆°ng 7 (A Randomized, Double Blind, Placebo Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy Shampoos TD03 and TD07 in Scalp Diseases)\n\n    **Match Score:** 0.00% | **Phase:** PHASE3 | **[NCT Link](https://clinicaltrials.gov/study/NCT03845348)**\n\n    **Why it fits:** No eligibility criteria available\n\n    **Conditions:** Scalp Dermatitis\n\n    **Locations:** Nationa Hospital of Dermatology, Hanoi, Vietnam\n\n3.  **NCT03845959** `COMPLETED`\n\n    ### NGHI√äN C·ª®U NG·∫™U NHI√äN, M√ô ƒê√îI, C√ì ƒê·ªêI CH·ª®NG TRONG ƒêI·ªÄU TR·ªä H·ªòI CH·ª®NG C·ªî VAI C√ÅNH TAY C·ª¶A VI√äN NANG C·ª®NG TD 0019 (A Randomized, Double Blind, Placebo Controlled, Parallel Group, Phase 3 Trial to Evaluate the Satety and Efficacy of Therapy With Hard Capsule TD0019 in Cervical Scapulohumeral Syndrome)\n\n    **Match Score:** 0.00% | **Phase:** PHASE2 | **[NCT Link](https://clinicaltrials.gov/study/NCT03845959)**\n\n    **Why it fits:** No eligibility criteria available\n\n    **Conditions:** Syndrome Pain\n\n    **Locations:** National Hospital of Traditional Medicine, Hanoi, Vietnam\n\n4.  **NCT01995617** `COMPLETED`\n\n    ### A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study to Evaluate the Safety, Tolerability, and Immunogenicity of GEN-004, a Streptococcus Pneumoniae Protein Subunit Vaccine, in Adult Subjects\n\n    **Match Score:** 0.00% | **Phase:** PHASE1 | **[NCT Link](https://clinicaltrials.gov/study/NCT01995617)**\n\n    **Why it fits:** No eligibility criteria available\n\n    **Conditions:** Streptococcus Pneumoniae\n\n    **Locations:** Prism Research, Saint Paul, Minnesota, United States\n\n5.  **NCT05721131** `COMPLETED`\n\n    ### NC Thermometer (Gen 3) ISO 80601-2-56 Validation\n\n    **Match Score:** 0.00% | **Phase:** N/A | **[NCT Link](https://clinicaltrials.gov/study/NCT05721131)**\n\n    **Why it fits:** No eligibility criteria available\n\n    **Conditions:** Febrile Illness, Fever, Healthy\n\n    **Locations:** Choice Health Network- Reyes Health Center, Anaheim, California, United States; Natural Cycles, New York, New York, United States\n\nI've provided the trial matches in the requested format. Let me know if you'd like me to elaborate on any of these trials or if you have any other questions.",
        "trial_ids": [
          "NCT06657495",
          "NCT03845348",
          "NCT03845959",
          "NCT01995617",
          "NCT05721131"
        ],
        "trial_count": 5,
        "execution_time": 16.5,
        "tokens": {
          "prompt_tokens": 1548,
          "completion_tokens": 952,
          "total_tokens": 2500
        },
        "llm_scores": {
          "trial_id_count": 5,
          "trial_ids_extracted": [
            "NCT06657495",
            "NCT03845348",
            "NCT03845959",
            "NCT01995617",
            "NCT05721131"
          ],
          "depth": 1,
          "depth_reasoning": "No real matching logic is applied to the patient‚Äôs condition (achondroplasia/FGFR3 mutation, age 3, new immigrant, untreated). All trials are clearly unrelated indications, and the only justification is the generic phrase ‚ÄúNo eligibility criteria available,‚Äù which does not explain why they would match this specific patient.",
          "relevance": 1,
          "relevance_reasoning": "User asks for trials for a 3-year-old girl with achondroplasia due to FGFR3 mutation. The listed studies are for knee osteoarthritis, scalp dermatitis, cervical scapulohumeral pain syndrome, pneumococcal vaccine in adults, and thermometer validation‚Äînone relevant to pediatric achondroplasia or growth disorders. The response does not address the actual clinical need.",
          "clarity": 4,
          "clarity_reasoning": "The response is well formatted, with clear headings, NCT IDs, status, and locations. It is easy to read and organized, despite being clinically inappropriate for the query.",
          "completeness": 1,
          "completeness_reasoning": "Key aspects of the patient profile (age, genetic diagnosis, skeletal dysplasia, growth concerns, lack of prior treatment, immigrant status) are completely ignored in selecting trials. No attempt is made to find or note absence of relevant FGFR3/achondroplasia or growth-related pediatric trials, so the core request is essentially unmet."
        }
      },
      "language": "vi"
    },
    {
      "topic_number": "8",
      "workflow": {
        "response": "Okay, I understand. I will act as a clinical trial matching assistant, presenting trial matches clearly and conversationally, following the specified format and tone guidelines. I will only use the provided matched trials and will respond in the same language as the user's input.\n\nHere are the trial matches for the patient you described:\n\n1.  **NCT06657495** `RECRUITING`\n\n    ### Th·ª≠ Nghi·ªám L√¢m S√†ng Giai ƒêo·∫°n 2, Ng·∫´u Nhi√™n, M√π ƒê√¥i, C√≥ ƒê·ªëi Ch·ª©ng Gi·∫£ D∆∞·ª£c ƒê·ªÉ ƒê√°nh Gi√° T√≠nh an To√†n V√† Hi·ªáu Qu·∫£ C·ªßa Vi√™n Ho√†n C·ª©ng TD0015 Tr√™n B·ªánh Nh√¢n Tho√°i H√≥a Kh·ªõp G·ªëi\n\n    **Match Score:** 0.00% | **Phase:** PHASE2 | **[NCT Link](https://clinicaltrials.gov/study/NCT06657495)**\n\n    **Why it fits:** No eligibility criteria available\n\n    **Conditions:** Knee Osteoarthritis\n\n    **Locations:** National Hospital of Traditional Medicine, Hanoi, Vietnam\n\n2.  **NCT03845348** `UNKNOWN`\n\n    ### ƒê√°nh gi√° hi·ªáu qu·∫£ ƒëi·ªÅu tr·ªã vi√™m da d·∫ßu ·ªü ƒë·∫ßu c·ªßa d·∫ßu g·ªôi Th√°i D∆∞∆°ng 3 v√† Th√°i D∆∞∆°ng 7 (A Randomized, Double Blind, Placebo Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy Shampoos TD03 and TD07 in Scalp Diseases)\n\n    **Match Score:** 0.00% | **Phase:** PHASE3 | **[NCT Link](https://clinicaltrials.gov/study/NCT03845348)**\n\n    **Why it fits:** No eligibility criteria available\n\n    **Conditions:** Scalp Dermatitis\n\n    **Locations:** Nationa Hospital of Dermatology, Hanoi, Vietnam\n\n3.  **NCT01241253** `COMPLETED`\n\n    ### Glycemic Response of Bean-and-rice Meals in Persons With Type 2 Diabetes Mellitus\n\n    **Match Score:** 0.00% | **Phase:** PHASE2 | **[NCT Link](https://clinicaltrials.gov/study/NCT01241253)**\n\n    **Why it fits:** No eligibility criteria available\n\n    **Conditions:** Blood Glucose, Type 2 Diabetes Mellitus\n\n    **Locations:** Arizona State University, Nutrition Program, Mesa, Arizona, United States\n\n4.  **NCT07049458** `NOT_YET_RECRUITING`\n\n    ### A Phase I/IIa, Open-Label, Dose-Escalation and Cohort-Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of CHO-A04 in Subjects With Advanced Solid Tumors\n\n    **Match Score:** 0.00% | **Phase:** PHASE1/PHASE2 | **[NCT Link](https://clinicaltrials.gov/study/NCT07049458)**\n\n    **Why it fits:** No eligibility criteria available\n\n    **Conditions:** Advanced Solid Tumors\n\n    **Locations:** Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan\n\n5.  **NCT03845959** `COMPLETED`\n\n    ### NGHI√äN C·ª®U NG·∫™U NHI√äN, M√ô ƒê√îI, C√ì ƒê·ªêI CH·ª®NG TRONG ƒêI·ªÄU TR·ªä H·ªòI CH·ª®NG C·ªî VAI C√ÅNH TAY C·ª¶A VI√äN NANG C·ª®NG TD 0019 (A Randomized, Double Blind, Placebo Controlled, Parallel Group, Phase 3 Trial to Evaluate the Satety and Efficacy of Therapy With Hard Capsule TD0019 in Cervical Scapulohumeral Syndrome)\n\n    **Match Score:** 0.00% | **Phase:** PHASE2 | **[NCT Link](https://clinicaltrials.gov/study/NCT03845959)**\n\n    **Why it fits:** No eligibility criteria available\n\n    **Conditions:** Syndrome Pain\n\n    **Locations:** National Hospital of Traditional Medicine, Hanoi, Vietnam\n\nI've provided the trial matches in the requested format. Let me know if you'd like me to elaborate on any of these trials or if you have any other questions.",
        "trial_ids": [
          "NCT06657495",
          "NCT03845348",
          "NCT01241253",
          "NCT07049458",
          "NCT03845959"
        ],
        "trial_count": 5,
        "execution_time": 15.62,
        "tokens": {
          "prompt_tokens": 1577,
          "completion_tokens": 950,
          "total_tokens": 2527
        },
        "llm_scores": {
          "trial_id_count": 5,
          "trial_ids_extracted": [
            "NCT06657495",
            "NCT03845348",
            "NCT01241253",
            "NCT07049458",
            "NCT03845959"
          ],
          "depth": 1,
          "depth_reasoning": "The assistant provides no clinical reasoning about why any trial fits this specific 7‚Äëmonth‚Äëold with Hirschsprung disease; every trial has \"Why it fits: No eligibility criteria available\" and the listed conditions (knee OA, scalp dermatitis, diabetes, advanced solid tumors, pain syndrome) are clearly unrelated to the patient profile.",
          "relevance": 1,
          "relevance_reasoning": "The user asks for trials for an infant with Hirschsprung disease; the response lists adult-focused trials on completely different conditions and never acknowledges the mismatch. It does not answer the user‚Äôs need in any meaningful way.",
          "clarity": 4,
          "clarity_reasoning": "The formatting is clear, organized by numbered trials with headings, status, phase, links, and locations. While the content is clinically inappropriate, it is easy to read and understand structurally.",
          "completeness": 1,
          "completeness_reasoning": "The response ignores essentially all key aspects of the patient profile (age, diagnosis, disease type, location relevance) and provides only irrelevant trials, with no attempt to address the actual condition or constraints; it is effectively non-responsive to the user‚Äôs clinical trial matching request."
        }
      },
      "language": "vi"
    },
    {
      "topic_number": "9",
      "workflow": {
        "response": "Okay, I've reviewed the patient information and the available clinical trials. Based on the provided details, here are some potential trial matches:\n\n1.  **NCT01933373** `COMPLETED`\n\n### A Prospective Randomized Trial Comparing Two Reconstructive Operation Techniques After Myotomy of Achalasia. Comparing Toupet Versus DOR.\n\n**Match Score:** 0.00% | **Phase:** NA | **[NCT Link](https://clinicaltrials.gov/study/NCT01933373)**\n\n**Why it fits:** The patient has a retained pouch in the esophagus, which is a key feature of achalasia. While the trial is completed, it might be relevant if the patient's symptoms worsen or if they are considering surgery.\n\n**Conditions:** Achalasia\n\n**Locations:** Karolinska University Hospital, Stockholm, Sweden\n\n---\n\n2.  **NCT02890836** `COMPLETED`\n\n### Blood Pressure, Antihypertensive Treatment and Preeclampsia in Pregnant Wom-en With Pre-existing Diabetes\n\n**Match Score:** 0.00% | **Phase:** NA | **[NCT Link](https://clinicaltrials.gov/study/NCT02890836)**\n\n**Why it fits:** The patient is not pregnant, so this trial is not relevant.\n\n**Conditions:** Pregnancy in Diabetics\n\n**Locations:** Center for Pregnant Women with Diabetes, Copenhagen, Kbh √ò, Denmark\n\n---\n\n3.  **NCT05473169** `UNKNOWN`\n\n### Evaluation of Swallowing in Patients With Vocal Folds Immobility\n\n**Match Score:** 0.00% | **Phase:** NA | **[NCT Link](https://clinicaltrials.gov/study/NCT05473169)**\n\n**Why it fits:** The patient has dysphagia and hoarseness, which could be related to vocal cord issues. However, the trial is currently unknown, and the patient's symptoms are more likely related to the esophageal pouch.\n\n**Conditions:** Swallowing Disorder\n\n**Locations:** N/A\n\n---\n\n4.  **NCT02988934** `TERMINATED`\n\n### The WATS3D (Wide Area Transepithelial Sample Biopsy With 3-Dimensional Computer-Assisted Analysis) U.S. Registry\n\n**Match Score:** 0.00% | **Phase:** NA | **[NCT Link](https://clinicaltrials.gov/study/NCT02988934)**\n\n**Why it fits:** The patient has a retained pouch in the esophagus, which is a key feature of achalasia. While the trial is terminated, it might be relevant if the patient's symptoms worsen or if they are considering surgery.\n\n**Conditions:** Barrett Esophagus, Esophageal Diseases, Esophageal Dysplasia, Gastroesophageal Reflux\n\n**Locations:** University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States\n\n---\n\n5.  **NCT04147507** `COMPLETED`\n\n### Effect of Relaxing Music on Blood Pressure and Resting Heart Rate Among Pre-hypertensive Young Adults\n\n**Match Score:** 0.00% | **Phase:** NA | **[NCT Link](https://clinicaltrials.gov/study/NCT04147507)**\n\n**Why it fits:** The patient has hypertension, but the trial is completed and not relevant to the patient's current condition.\n\n**Conditions:** Blood Pressure, Prehypertension, Resting Heart Rate\n\n**Locations:** Universiti Tunku Abdul Rahman, Kajang, Selangor, Malaysia\n\n---\n\nI've done my best to find trials that might be relevant based on the information you provided. I hope this is helpful! Let me know if you have any other questions.",
        "trial_ids": [
          "NCT01933373",
          "NCT02890836",
          "NCT05473169",
          "NCT02988934",
          "NCT04147507"
        ],
        "trial_count": 5,
        "execution_time": 14.12,
        "tokens": {
          "prompt_tokens": 1255,
          "completion_tokens": 839,
          "total_tokens": 2094
        },
        "llm_scores": {
          "trial_id_count": 5,
          "trial_ids_extracted": [
            "NCT01933373",
            "NCT02890836",
            "NCT05473169",
            "NCT02988934",
            "NCT04147507"
          ],
          "depth": 2,
          "depth_reasoning": "Provides brief ‚Äòwhy it fits‚Äô comments but the clinical reasoning is shallow and often incorrect (e.g., mislabeling a Zenker diverticulum-like pouch as achalasia, not integrating age/comorbidities, and not carefully matching inclusion criteria). Several trials are explicitly acknowledged as not relevant, showing limited true matching logic.",
          "relevance": 2,
          "relevance_reasoning": "User asked for clinical trials for an older woman with probable Zenker diverticulum. Most listed trials are completed, terminated, or clearly unrelated (pregnancy in diabetics, pre-hypertensive young adults). Only one swallowing-related trial is tangentially relevant, and even that is not clearly applicable. Overall, the response does not effectively provide relevant, actionable trial options for this specific condition.",
          "clarity": 4,
          "clarity_reasoning": "The response is well-formatted with numbered trials, consistent structure, and short explanations. Easy to read and understand, despite some clinical inaccuracies. Minor issues in clinical wording but not in general clarity or organization.",
          "completeness": 2,
          "completeness_reasoning": "Does not address key aspects of the patient‚Äôs likely diagnosis (Zenker diverticulum), age, functional status, or comorbidities when selecting trials. Most suggestions are inapplicable due to status (completed/terminated) or off-topic conditions. It neither screens out irrelevant trials effectively nor attempts to identify truly appropriate interventional or observational trials for this esophageal pouch condition, leaving major gaps relative to the user‚Äôs request."
        }
      },
      "language": "vi"
    },
    {
      "topic_number": "10",
      "workflow": {
        "response": "Okay, I've reviewed the patient information and the available clinical trials. Here are some potential matches:\n\n1.  **NCT07092852** `NOT_YET_RECRUITING`\n\n    ### Pharmacogenomic-Based Medication Safety Reviews of Persons With Intellectual and Developmental Disabilities\n\n    **Match Score:** 0.00% | **Phase:** NA | **[NCT Link](https://clinicaltrials.gov/study/NCT07092852)**\n\n    **Why it fits:** This trial focuses on individuals with intellectual and developmental disabilities. While the patient's condition isn't explicitly stated as such, the trial's focus on these populations makes it a potential match.\n\n    **Conditions:** Developmental Disability, Intellectual Disability, Mild, Intellectual Disability, Mild to Moderate\n    **Locations:** CP Unlimited, The Bronx, New York, United States; GalenusRx, Inc., Montverde, Florida, United States\n\n2.  **NCT06525467** `COMPLETED`\n\n    ### Primary Renal Lymphoma: a Case Report and Review of the Literature\n\n    **Match Score:** 0.00% | **Phase:** NA | **[NCT Link](https://clinicaltrials.gov/study/NCT06525467)**\n\n    **Why it fits:** This trial is about renal lymphoma. The patient's condition is not renal lymphoma.\n\n    **Conditions:** Renal Lymphoma\n    **Locations:** Mexican Institute Of Social Health, M√©rida, Yucat√°n, Mexico\n\n3.  **NCT00044174** `COMPLETED`\n\n    ### Dyadic Interactions in Depressed and Non-Depressed Mothers With Their Infants\n\n    **Match Score:** 0.00% | **Phase:** NA | **[NCT Link](https://clinicaltrials.gov/study/NCT00044174)**\n\n    **Why it fits:** This trial is about depression in mothers. The patient's condition is not depression.\n\n    **Conditions:** Depression\n    **Locations:** National Institutes of Health Clinical Center, Bethesda, Maryland, United States\n\n4.  **NCT05428514** `UNKNOWN`\n\n    ### Evaluating the Impact of Emergency Maternity Housing on Mother and Child Well-being, Housing, and Employment\n\n    **Match Score:** 0.00% | **Phase:** NA | **[NCT Link](https://clinicaltrials.gov/study/NCT05428514)**\n\n    **Why it fits:** This trial is about maternity housing. The patient's condition is not maternity housing.\n\n    **Conditions:** Housing Problems, Pregnancy Related\n    **Locations:** University of Notre Dame, Notre Dame, Indiana, United States\n\n5.  **NCT05218603** `UNKNOWN`\n\n    ### A Prospective, Observational Study, to Evaluate the Maintenance With Bortezomib Plus Daratumumab (V-Dara) After Induction With Bortezomib, Melphalan, Prednisone Plus Daratumumab (VMP-Dara) in Newly Diagnosed Multiple Myeloma (MM) Patients Non-eligible for Autologous Stem Cell Transplantation (ASCT): Alcyone-optimized Real World Evidence (RWE) Data\n\n    **Match Score:** 0.00% | **Phase:** NA | **[NCT Link](https://clinicaltrials.gov/study/NCT05218603)**\n\n    **Why it fits:** This trial is about multiple myeloma. The patient's condition is not multiple myeloma.\n\n    **Conditions:** Multiple Myeloma, Non-eligible for Autologous Stem Cell Transplantation (ASCT)\n    **Locations:** Clinica Universidad de Navarra, Pamplona, Spain; Complejo Asistencial de Avila, √Åvila, Spain; Complejo Hospitalario Universitario de Gran Canaria Dr. Negr√≠n, Las Palmas de Gran Canaria, Spain; Complejo Hospitalario de Ja√©n, Ja√©n, Spain\n\nI'm sorry, but I couldn't find any trials that match the patient's condition.",
        "trial_ids": [
          "NCT07092852",
          "NCT06525467",
          "NCT00044174",
          "NCT05428514",
          "NCT05218603"
        ],
        "trial_count": 5,
        "execution_time": 15.07,
        "tokens": {
          "prompt_tokens": 1355,
          "completion_tokens": 888,
          "total_tokens": 2243
        },
        "llm_scores": {
          "trial_id_count": 5,
          "trial_ids_extracted": [
            "NCT07092852",
            "NCT06525467",
            "NCT00044174",
            "NCT05428514",
            "NCT05218603"
          ],
          "depth": 2,
          "depth_reasoning": "The assistant lists several trials and gives brief \"why it fits\" notes, but these are mostly incorrect or trivial (often stating the trial is about a different condition). There is no real clinical reasoning connecting the patient‚Äôs actual problem (likely a benign wrist ganglion in a healthy 19-year-old) to the trials. Depth is slightly above 1 only because there is at least some commentary, but it is not meaningful matching logic.",
          "relevance": 2,
          "relevance_reasoning": "The user asked to find clinical trials for a specific young woman with a wrist mass. The response lists unrelated trials (developmental disability, renal lymphoma, depression, maternity housing, multiple myeloma) and then concludes no trials match. The majority of the content is about irrelevant trials, though the closing acknowledgment that no matches were found is loosely related to the request.",
          "clarity": 4,
          "clarity_reasoning": "The response is clearly formatted and easy to read, with numbered trials, titles, conditions, and locations. Language and structure are understandable. The issue is not clarity but correctness and relevance, so clarity score remains relatively high.",
          "completeness": 2,
          "completeness_reasoning": "The response does not meaningfully address the patient profile: it ignores the likely diagnosis, age, functional status, and specific condition in trial selection. It neither finds relevant trials nor explains that none exist for this specific benign condition with appropriate reasoning. Many key aspects of the patient profile (orthopedic/hand condition, need to type, otherwise healthy young woman) are not used in matching. The final statement of no matches is incomplete without proper justification or exploration of nearby relevant areas."
        }
      },
      "language": "vi"
    }
  ],
  "average_scores": {
    "workflow": {
      "trial_id_count": 4.1,
      "depth": 2.1,
      "relevance": 2.0,
      "clarity": 4.1,
      "completeness": 1.9,
      "trial_count_avg": 4.1,
      "execution_time_avg": 13.32,
      "avg_prompt_tokens": 1388.6,
      "avg_completion_tokens": 778.5,
      "avg_total_tokens": 2167.1,
      "total_prompt_tokens": 13886,
      "total_completion_tokens": 7785,
      "total_tokens": 21671,
      "total_scored": 10
    }
  }
}